Skip to main content
. 2021 Oct 13;28:10–20. doi: 10.1016/j.jor.2021.10.002

Table 2.

Primary THA indications and implant features; AVN avascular necrosis.

THA indication, n (%) Coxarthrosis 11 (73.3)
Post-traumatic coxarthrosis 2 (13.3)
Hip dysplasias 1 (6.7)
AVN of femoral head 1 (6.7)
Bearing surfaces, n (%) MoM 12 (80)
MoP 3 (20)
Mean (range) implant survivorship (years) MoM 6.9 (2–10)
MoP 18.3 (14–22)
Tot. 9.2 (2–22)